# ClinicalTrialStartPulse: this week's new records **ClinicalTrialStartPulse added 25 new public records since 2026-10-28; the newest is dated 2026-11-03. The list updates automatically from the source data, and each item links to its full record and the official source. A free weekly email version is available with confirmed opt-in.** 25 new public records since 2026-10-28, newest first. Updated automatically from the ClinicalTrialStartPulse source data. - [Genmab: Phase 3 study started recruiting, 600 planned (Colorectal Cancer)](/report/clinicaltrialstartpulse/genmab-us--nct-nct07775287-recruiting) 2026-11-03 - [GlaxoSmithKline: Phase 3 study started recruiting, 610 planned (Neoplasms, Endometrial)](/report/clinicaltrialstartpulse/glaxosmithkline-nonus--nct-nct07684599-recruiting) 2026-11-03 - [Merck Sharp & Dohme LLC: Phase 3 study started recruiting, 1104 planned (Diabetic Retinopathy, Macular Edema)](/report/clinicaltrialstartpulse/merck-sharp-and-dohme-llc-us--nct-nct07705607-recruiting) 2026-11-03 - [NervGen Pharma: Phase 3 study started recruiting, 150 planned (Chronic Spinal Cord Injury)](/report/clinicaltrialstartpulse/nervgen-pharma-us--nct-nct07799532-recruiting) 2026-11-03 - [Nurix Therapeutics, Inc.: Phase 2 study started recruiting, 150 planned (B-cell Lymphoma, Chronic Lymphocytic Leukemia)](/report/clinicaltrialstartpulse/nurix-therapeutics-inc-us--nct-nct07520006-recruiting) 2026-11-03 - [Janssen Research & Development, LLC: Phase 2 study closed enrollment, 333 enrolled (Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct05963074-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 2 study closed enrollment, 166 enrolled (Lymphoma, Non-Hodgkin, Lymphoma, B-Cell)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct05421663-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 2 study closed enrollment, 305 enrolled (Carcinoma, Non-Small-Cell Lung)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct06120140-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 3 study closed enrollment, 743 enrolled (Multiple Myeloma)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct04923893-enrollment) 2026-11-03 - [Janssen-Cilag Ltd.: Phase 3 study closed enrollment, 120 enrolled (Crohn's Disease)](/report/clinicaltrialstartpulse/janssen-cilag-ltd-us--nct-nct06408935-enrollment) 2026-11-03 - [Genmab: Phase 3 study closed enrollment, 191 enrolled (PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC)](/report/clinicaltrialstartpulse/genmab-us--nct-nct06635824-enrollment) 2026-11-03 - [Janssen-Cilag Ltd.: Phase 3 study closed enrollment, 288 enrolled (Fistulizing Crohns Disease, Perianal Crohns Disease)](/report/clinicaltrialstartpulse/janssen-cilag-ltd-us--nct-nct05347095-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 2 study closed enrollment, 168 enrolled (Multiple Myeloma)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct07266441-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 3 study closed enrollment, 539 enrolled (Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct01804686-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 3 study closed enrollment, 159 enrolled (Crohn Disease, Colitis, Ulcerative)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct05092269-enrollment) 2026-11-03 - [AstraZeneca: Phase 3 study closed enrollment, 181 enrolled (Chronic Rhinosinusitis With Nasal Polyps)](/report/clinicaltrialstartpulse/astrazeneca-us--nct-nct06706817-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 3 study closed enrollment, 864 enrolled (Multiple Myeloma)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct05455320-enrollment) 2026-11-03 - [Teva Branded Pharmaceutical Products R&D LLC: Phase 2 study closed enrollment, 349 enrolled (Multiple System Atrophy)](/report/clinicaltrialstartpulse/teva-branded-pharmaceutical-products-r-and-d-llc-us--nct-nct06568237-enrollment) 2026-11-03 - [Genmab: Phase 2 study closed enrollment, 543 enrolled (Diffuse Large B-Cell Lymphoma, Follicular Lymphoma)](/report/clinicaltrialstartpulse/genmab-us--nct-nct04663347-enrollment) 2026-11-03 - [Janssen Pharmaceutica N.V., Belgium: Phase 3 study closed enrollment, 691 enrolled (Prostatic Neoplasms)](/report/clinicaltrialstartpulse/janssen-pharmaceutica-n-v-belgium-us--nct-nct04557059-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 2 study closed enrollment, 208 enrolled (Multiple Myeloma)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct04133636-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 2 study closed enrollment, 235 enrolled (Non-Muscle Invasive Bladder Neoplasms)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct05316155-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 3 study closed enrollment, 112 enrolled (Colitis, Ulcerative)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct06260163-enrollment) 2026-11-03 - [Apogee Therapeutics, Inc.: Phase 2 study closed enrollment, 470 enrolled (Atopic Dermatitis)](/report/clinicaltrialstartpulse/apogee-therapeutics-inc-us--nct-nct06395948-enrollment) 2026-11-03 - [Janssen Research & Development, LLC: Phase 2 study closed enrollment, 189 enrolled (Dermatitis, Atopic)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-us--nct-nct07230860-enrollment) 2026-11-03 ## Get this digest by email (free) We will email you one confirmation link now. The weekly digest starts only after you confirm, and every email has a one-click unsubscribe. Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe. [Search and filter all records](/v/clinicaltrialstartpulse?channel=digest) [RSS](/feed/clinicaltrialstartpulse.xml) ## Often used together - [NihBiotechGrantPulse](/v/nihbiotechgrantpulse) - [FDAPulse](/v/fdapulse) - [WaLobbyistEmploymentRegistrationsPulse](/v/walobbyistemploymentregistratpulse) - [SecurityIntegratorNdaaAudit](/securityintegratorndaaaudit) - [CoreWebVitalsPulse](/corewebvitalspulse) - [CookieConsentPulse](/cookieconsentpulse)